Life Sciences

Insights brief: Advancing outcomes-based contracting

Share this post:

The shift from volume to value in health care has presented life sciences companies with tremendous challenges and opportunities to proactively manage cost pressure and scientific innovation.


Truven Health Analytics®, an IBM Watson Health™ business, held discussions with more than a dozen life sciences companies to gather in-depth insights on their experience and intentions for outcomes-based contracts (OBCs). Viewed as an innovative way to improve patients’ access to the right therapies, life sciences companies are facing strategic and tactical challenges implementing OBCs.


In this brief, we share insights on the challenges in managing outcomes-based contracts (OBCs) with health plans today and solutions to address these challenges, based on our conversations with life sciences companies.


More Life Sciences Stories

How IHMI is Changing Health Care Delivery

Written by Watson Health | Blog Post, Cognitive Computing, Healthcare Data Analytics

A Q&A with James Madara, MD, CEO, American Medical Association on how health care delivery will be changing through an integrated-data approach model with IHMI. more